Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 3 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia.
Am J Hematol. 2023 Jun;98(6):E142-E144. doi: 10.1002/ajh.26907. Epub 2023 Mar 16.
Am J Hematol. 2023.
PMID: 36877196
No abstract available.
Myeloid lineage switch in KMT2A-rearranged acute lymphoblastic leukemia treated with lymphoid lineagedirected therapies.
Bataller A, Abuasab T, McCall D, Wang W, Cuglievan B, Issa GC, Jabbour E, Short N, DiNardo CD, Tang G, Garcia-Manero G, Kantarjian HM, Sasaki K.
Bataller A, et al. Among authors: abuasab t.
Haematologica. 2024 Jan 1;109(1):293-297. doi: 10.3324/haematol.2023.283705.
Haematologica. 2024.
PMID: 37646654
Free PMC article.
No abstract available.
Item in Clipboard
Emerging Monoclonal Antibody Therapy for the Treatment of Acute Lymphoblastic Leukemia.
Abuasab T, Rowe J, Tvito A.
Abuasab T, et al.
Biologics. 2021 Oct 18;15:419-431. doi: 10.2147/BTT.S290294. eCollection 2021.
Biologics. 2021.
PMID: 34703207
Free PMC article.
Review.
Item in Clipboard
Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 study.
Bazinet A, Garcia-Manero G, Short N, Alvarado Y, Bataller A, Abuasab T, Islam R, Montalbano K, Issa G, Maiti A, Yilmaz M, Jain N, Masarova L, Kornblau S, Jabbour E, Montalban-Bravo G, Rausch CR, Pierce S, DiNardo CD, Kadia T, Daver N, Konopleva M, Huang X, Kantarjian H, Ravandi F.
Bazinet A, et al. Among authors: abuasab t.
Lancet Haematol. 2024 Apr;11(4):e276-e286. doi: 10.1016/S2352-3026(24)00033-4. Epub 2024 Mar 4.
Lancet Haematol. 2024.
PMID: 38452788
Clinical Trial.
Item in Clipboard
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens.
Senapati J, Abuasab T, Haddad FG, Ravandi F, Kadia T, DiNardo C, Daver N, Pemmaraju N, Alvarado Y, Brandt MA, Kantarjian H, Borthakur G.
Senapati J, et al. Among authors: abuasab t.
Am J Hematol. 2023 Mar;98(3):E53-E56. doi: 10.1002/ajh.26811. Epub 2022 Dec 24.
Am J Hematol. 2023.
PMID: 36565294
Free article.
No abstract available.
Item in Clipboard
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications.
Abuasab T, Borthakur G, Kanagal-Shamanna R, Masarova L, Patel K, Takahashi K, Bose P, Villarreal J, Pierce S, Kadia T, Garcia-Manero G, Short NJ, DiNardo C, Daver N, Ravandi F, Kantarjian H, Verstovsek S, Yilmaz M.
Abuasab T, et al.
Am J Hematol. 2024 Apr 13. doi: 10.1002/ajh.27333. Online ahead of print.
Am J Hematol. 2024.
PMID: 38613831
No abstract available.
Item in Clipboard
Cite
Cite